医学
多发性骨髓瘤
坏疽性脓皮病
不确定意义的单克隆抗体病
游戏病
疾病
化疗
皮肤病科
骨病
病理
单克隆
内科学
免疫学
抗体
单克隆抗体
骨质疏松症
作者
Jiajie Lyu,Wei Sun,Hanshuo Zhang,Shengxiu Liu
出处
期刊:Wounds-a Compendium of Clinical Research and Practice
[HMP Communications, LLC]
日期:2022-01-01
卷期号:34 (11): e108-e111
被引量:1
摘要
PG is an uncommon, noninfectious neutrophilic dermatosis. Very few cases of bullous PG as the first manifestation of IgG myeloma have been reported. HE4, a novel marker for human cancers, may be a promising marker of bone destruction and disease progression in patients with hematologic malignancies and PG lesions.The authors report a case of a 49-year-old female who presented with painful patches located on the lower extremities for the past 5 months, and then had lesions that rapidly progressed to necrotic ulcers after unregulated acupuncture therapy. During the treatment procedure, underlying IgG κ-type myeloma was diagnosed. After the diagnosis was confirmed, the patient underwent chemotherapy, and the lesions started to heal and gradually showed scarring. The current report also discusses the potential value of HE4 as applied to malignancies that present with PG and bone destruction.Once the diagnosis of the underlying systemic disease is confirmed, patients with PG should simultaneously receive aggressive treatment for the primary disease. More emphasis should be put on HE4 regarding the progression of monoclonal gammopathy-related PG with bone destruction to provide new ideas to understand the pathogenesis of this disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI